Compounds > erythromycin

Page last updated: 2024-08-21

erythromycin and niacin

erythromycin has been researched along with niacin in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (16.67)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (8.33)	29.6817
2010's	9 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA	1
Bellman, K; Knegtel, RM; Settimo, L	1
Bouillon, A; Cresteil, T; Fontaine, F; Hequet, A; Jolivalt, C; Lesnard, A; Rault, S; Voisin-Chiret, AS	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
FLIPPIN, HF; FOLTZ, EL	1
BROWN, RL; EVANS, JB	1

Reviews

1 review(s) available for erythromycin and niacin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

11 other study(ies) available for erythromycin and niacin

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling. Journal of medicinal chemistry, 2013, Feb-14, Volume: 56, Issue:3 Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs	2013
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump. Journal of medicinal chemistry, 2014, Mar-27, Volume: 57, Issue:6 Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Proteins; Boronic Acids; Cell Survival; Ciprofloxacin; Culture Media; Drug Resistance, Bacterial; Drug Screening Assays, Antitumor; Humans; Indicators and Reagents; KB Cells; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Staphylococcus aureus; Structure-Activity Relationship	2014
The newer antimicrobial agents. American practitioner and digest of treatment, 1953, Volume: 4, Issue:9 Topics: Anti-Bacterial Agents; Erythromycin; Humans; Niacin; Nicotinic Acids; Penicillins; Probenecid; Sulfonamides	1953
COMPARATIVE PHYSIOLOGY OF ANTIBIOTIC-RESISTANT STRAINS OF STAPHYLOCOCCUS AUREUS. Journal of bacteriology, 1963, Volume: 85 Topics: Anti-Bacterial Agents; Chloramphenicol; Coagulase; Drug Resistance, Microbial; Erythromycin; Glucose; Humans; Hydrolases; Mannitol; Metabolism; Micrococcus; Neomycin; Niacin; Nicotinic Acids; Novobiocin; Oleandomycin; Penicillins; Pyruvates; Research; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Streptomycin; Tetracycline; Thiamine	1963